Form 4: Dolby Laboratories CEO Transfers Stock Options to Revocable Trust

Dolby Laboratories CEO Kevin Yeaman transferred stock options to a revocable trust for estate planning purposes on February 27, 2025.

Summary

• On February 27, 2025, Kevin Yeaman, the President and CEO of Dolby Laboratories, Inc., transferred employee stock options to a revocable trust.
• The transfer involved options for 95,671 shares of Class A Common Stock.
• The purpose of the transfer was for estate planning.
• The options were originally granted with a vesting schedule that began on December 16, 2024, with 1/4 vesting on the first anniversary and the remainder vesting monthly over the following 36 months.
• The exercise price of the options is $77.91.
• The expiration date of the options is December 16, 2034.
• The transfer was made to the Kevin and Rachel Yeaman Family Trust dated May 14, 2009.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing related to an executive's personal financial planning. It doesn't inherently indicate positive or negative sentiment regarding the company's performance.

Positives

• The transfer to a revocable trust can be a beneficial estate planning strategy for the executive.

Industry Context

Executive stock option transfers to trusts are a common estate planning practice.

Stakeholder Impact

• The transfer of stock options to a trust has minimal direct impact on Dolby Laboratories' stakeholders.

Key Dates